We are live on ! Find out more
ASMB icon

Assembly Biosciences
ASMB

34 hedge funds and large institutions have $37.2M invested in Assembly Biosciences in 2013 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 8 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

90% more call options, than puts

Call options by funds: $211K | Put options by funds: $111K

40% more capital invested

Capital invested by funds: $26.7M → $37.2M (+$10.6M)

38% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 8

8% less funds holding

Funds holding: 37 → 34 (-3)

30% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 10

Holders
34
Holders Change
-3
Holders Change %
-8.11%
% of All Funds
0.99%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
11
Reduced
8
Closed
10
Calls
$211K
Puts
$111K
Net Calls
+$100K
Net Calls Change
+$172K

Top Buyers

Rank Fund Capital Flow
1
VAM
Visium Asset Management
New York
+$910K
2
TC
TFS Capital
Pennsylvania
+$657K
3
BIT
BlackRock Institutional Trust
California
+$552K
4
JGC
J. Goldman & Co
New York
+$531K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$248K

Top Sellers

Rank Fund Capital Flow
1
Deutsche Bank
Deutsche Bank
Germany
-$937K
2
SC
Sophrosyne Capital
New York
-$637K
3
Group One Trading
Group One Trading
Illinois
-$114K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$92.7K
5
FNYS
First New York Securities
New York
-$91K
Name Holding Trade Value Shares
Change 		Change in
Stake
BA
26
BlackRock Advisors
Delaware
$26K +$5.46K +30 +35%
Wells Fargo
27
Wells Fargo
California
$8K +$2.91K +16 +94%
U
28
UBS
Switzerland
$5K -$31.1K -171 -90%
BNP Paribas Financial Markets
29
BNP Paribas Financial Markets
France
$4.53K +$3.64K +20 New
Bank of America
30
Bank of America
North Carolina
$2K +$1.46K +8 New
Citigroup
31
Citigroup
New York
$1K -$728 -4 -40%
HCC
32
Hirtle Callaghan & Co
Pennsylvania
$1K – – –
Manulife (Manufacturers Life Insurance)
33
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$2 – – –
SC
34
Sophrosyne Capital
New York
– -$637K -3,681 Closed
Group One Trading
35
Group One Trading
Illinois
– -$114K -628 Closed
Susquehanna International Group
36
Susquehanna International Group
Pennsylvania
– -$92.7K -509 Closed
SIM
37
Spark Investment Management
New York
– -$56K -325 Closed
State Street
38
State Street
Massachusetts
– -$45K -265 Closed
BG
39
BlackRock Group
United Kingdom
– -$37K -214 Closed
William Blair & Company
40
William Blair & Company
Illinois
– -$36K -208 Closed
Barclays
41
Barclays
United Kingdom
– -$17.1K -94 Closed
TRCT
42
Tower Research Capital (TRC)
New York
– -$4K -25 Closed
WF
43
WealthTrust Fairport
Ohio
– -$1K -8 Closed
1
2

ASMB Hedge Fund Activity: Q4 2013 in Review

34 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Assembly Biosciences (ASMB) for Q4 2013, worth a combined $37.2M — up 40% from $26.7M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of ASMB and 7 opened new positions — a net loss of 3 holders — while 8 trimmed existing stakes and 11 added.

The largest buyer was Visium Asset Management, adding an estimated $910K. The largest seller was Deutsche Bank, cutting an estimated $937K.

  • 34 institutional investors held Assembly Biosciences (ASMB) as of Q4 2013, down from 37 in Q3 2013.
  • Funds reported $37.2M of Assembly Biosciences stock for Q4 2013, up 40% quarter-over-quarter.
  • 7 funds opened new Assembly Biosciences positions in Q4 2013 and 10 closed out, a net change of -3 holders.
  • The largest Assembly Biosciences buyer in Q4 2013 was Visium Asset Management, an estimated $910K added.
  • The largest Assembly Biosciences seller in Q4 2013 was Deutsche Bank, an estimated $937K sold.

Based on aggregated 13F filings for Q4 2013.